children who received no vaccination (22%, 6/27) than among those with unknown vaccination history (10%, 15/157). Of 5 vaccinated children, 1 had JE; however, verification of this child's vaccination was not possible. Among 71 children who had no evidence of JE but for whom serum samples were available for testing, 5 had antibodies against mumps virus, 8 against echoviruses, and 5 against coxsackieviruses. Viral cultures of CSF from all 189 children were negative.
Our finding of 10.4 JE cases per 100,000 children <15 years of age in Dehong Prefecture is higher than the estimated incidence of 5.4 cases per 100,000 population among children <14 years of age in JE-endemic countries (2) . Nevertheless, the true JE population incidence for Dehong Prefecture might be underestimated if some children received no medical care or were admitted to other hospitals. Adults were not studied; however, ≈90% of JE cases in China are reported among children <15 years of age (5, 6) . Unfortunately, accurate age-adjusted JE vaccination coverage data for Dehong Prefecture are not available. Although vaccination programs have markedly lowered JE incidence in China in recent years (5, 6) , the finding of continuing high JE incidence in Dehong Prefecture warrants further attention. 
Novel Hantavirus in Field Vole, United Kingdom
To the Editor: Hantaviruses (family Bunyaviridae) are transmitted to humans by inhalation of aerosolized virus in contaminated urine and feces, mainly from rodents of the families Cricetidae and Muridae. Although infections in rodents are asymptomatic, infections in humans can lead to hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome (1).
In Europe, 5 rodent-borne hantaviruses have been detected: Dobrava-Belgrade, Saaremaa, Seoul, Puumala, and Tula (1, 2) . The most common and widespread hantavirus in Europe is Puumala virus, which is associated with the mildest form of hemorrhagic fever with renal syndrome (1).
In the United Kingdom, only a few cases of hantavirus infection in humans have been reported and confirmed serologically, but the causative virus species were not identified (3, 4 conditions allowed, blood samples were collected; otherwise, heart tissue was collected. Samples, and carcasses that could not be processed within 2 hours, were stored at -80°C.
RNA was extracted by using TRIzol Reagent (Invitrogen, Life Technologies, Paisley, UK). To detect hantavirus RNA, we used a nested pan-hantavirus reverse transcription PCR selective for partial polymerase large segment (L) gene sequences (5) . With the exception of 1 male field vole (B41) collected near Tattenhall, Cheshire (online Technical Appendix Figure) , all lung samples were negative for hantavirus RNA. The positive amplicon was sequenced by using a BigDye Terminator 3.1v Cycle Sequencing Kit on an ABI3130xl genetic analyzer (Applied Biosystems/Life Technologies, Paisley, UK) (GenBank accession no. JX316008). Partial small segment (S) sequences were also recovered from lung RNA from vole B41 (GenBank accession no. JX316009) (online Technical Appendix Table) . Established reverse transcription PCRs for the medium segment were unsuccessful.
Comparisons of nucleotide and amino acid sequence identities demonstrated, as expected, that the Arvicolinae-associated hantaviruses showed the highest similarity to the UK sequence at the nucleotide (65.7%-78.8% for S and 76.6%-77.5% for L) and the amino acid (66.4%-86.3% for S and 80%-88% for L) levels (online Technical Appendix Table) .
Phylogenetic analyses of partial L (Figure, panel A) and partial S sequences ( Figure, panel B) confirm the inclusion of the viral sequence from vole B41 as a distinct member of the Arvicolinae-associated hantaviruses. In the partial L tree ( Figure, panel  A) , viral sequence B41 clustered with Prospect Hill and Tula viruses with good support, although in the partial S tree (Figure, panel B) , B41 seems to be more closely related to the Asian Microtus vole-associated hantaviruses, albeit with low posterior probability values. These differences in tree topologies probably reflect different compositions of the sequence datasets. Blood collected from vole B41 was positive for hantavirus-specific antibodies (indirect fluorescent antibody test that used Puumala antigen) (8), suggesting cross-reactivity, as would be expected for Arvicolinaeassociated hantaviruses. Hantavirus RNA was detected in the kidneys but not the liver of vole B41 and not in the lungs, liver, or kidneys of the 7 other field voles. Degenerate cytochrome B gene PCR and sequencing (9) were used to confirm the morphologic identification of the field voles (B41 CytB GenBank accession no. KC222031).
The nucleotide and amino acid sequence divergences between B41 and the most related hantaviruses correspond to that typically found between hantavirus species (5) . The phylogenetic analyses further support B41 as a distinct hantavirus. Thus, we propose to name this novel virus Tatenale virus, reflecting the medieval name of its place of origin.
M. agrestis voles, among the most numerous mammals in mainland Britain, have not been shown to be primary carriers of a specific hantavirus, although recent studies suggest that they might be involved in the maintenance of Tula virus in Germany (10) . Further surveillance is needed to confirm that M. agrestis voles are the reservoir hosts of Tatenale virus, provide an estimate of virus prevalence, and determine zoonotic risk. Current knowledge of other Microtus vole-borne hantaviruses suggests that although they might infect humans, their pathogenic potential is generally low (1) . Future work will involve attempts to isolate Tatenale virus and generate its full-genome sequence.
Because hantavirus diseases have such broad clinical features, many cases among humans in the United Kingdom might be misdiagnosed. The confirmation of a novel hantavirus in indigenous wildlife in the United Kingdom might promote inclusion of hantavirus infection in the differential diagnosis for patients with acute renal failure, undiagnosed febrile illness, and exposure to rodents (4).
